What are Perspective Therapeutics's profit margins?

Perspective Therapeutics (CATX) runs a 33.1% gross margin and a -292.7% operating margin, with a -218.4% net margin.

Where do Perspective Therapeutics's ratios come from?

Every ratio is computed from Perspective Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Perspective Therapeutics CATX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-35.2%-2.1pp	-41.4%+1.9pp	-37.1%-7.2pp	-31.3%-5.1pp	-33.1%+0.5pp
Return on assets	-30%-2.0pp	-33.9%+2.2pp	-30.8%-5.4pp	-27.3%-3.9pp	-28%+0.7pp
Return on invested capital	-44.3%+15.3pp	-55%+5.2pp	-73.1%—	-65.7%—	-59.6%—
Liquidity
Current ratio	8.7×-8.3×	5.2×-7.5×	8.7×-0.9×	15.1×-12.6×	17×+4.0×
Quick ratio	8.7×-8.3×	5.2×-7.5×	8.7×-0.9×	15.1×-12.6×	17×+4.0×
Cash ratio	1.7×-1.8×	1.1×-2.3×	1.3×-6.7×	2.2×-21.5×	3.5×-6.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$3.35-14.8%	$2.80-37.8%	$3.26-29.9%	$3.58-30.0%	$3.93-15.3%
Valuation
Market capitalization	$342.14M+33.2%	$204.43M-5.2%	$254.72M-71.7%	$283.55M-57.8%	$157.73M-77.4%
Enterprise value	$292.34M+35.2%	$177M+12.0%	$231.22M-65.9%	$258.22M-39.1%	$117.09M-79.1%
Price / book	1×+0.1×	1×+0.2×	1.1×-1.7×	1.1×-0.9×	0.6×-2.5×
Free cash flow yield	-31.4%+9.0pp	-46.6%-12.9pp	-41.9%-37.4pp	-40.5%—	-65.8%—
Earnings yield	-32.5%+0.7pp	-50.4%-13.7pp	-41.5%-34.4pp	-33.5%-24.7pp	-54%-45.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Perspective Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Perspective Therapeutics's profit margins?: Perspective Therapeutics (CATX) runs a 33.1% gross margin and a -292.7% operating margin, with a -218.4% net margin.
Where do Perspective Therapeutics's ratios come from?: Every ratio is computed from Perspective Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.